Antigen localization and mechanism
The pathogenesis of type II reactions always begins with antibodies finding their target on the cell surface. This antigen can have a dual origin. First, it may be a natural component of the cell membrane (plasmalemma), acting as an endogenous self-antigen. Second, it can be an exogenous (foreign) antigen adsorbed onto the surface of an initially healthy cell.
The essence of the pathological reaction is that the binding of an antibody to normal or altered cellular structures triggers one of three antibody-dependent mechanisms.
Complement-dependent reactions
In this mechanism, the primary role is played by IgM or IgG antibodies, which work in close coordination with the complement system. Target cell damage is executed through two pathways:
- Direct lysis. Antibodies react with antigens on the cell surface, triggering the activation of the complement system. The process follows a strict cascade: after the binding of the epitope to IgG and the C1q component, the factors C1, C4, C2, C3 are sequentially activated, followed by C5b, C6, C7, C8 and C9. As a result, the membrane attack complex (MAC) assembles on the membrane. It disrupts the integrity of the cell wall, leading to direct lysis (death) of the cell.
- Opsonization. In this case, antibodies or the specific complement component C3b are fixed on the cell surface. The cell becomes "tagged" (opsonized) and turns into an attractive target for phagocytes, ultimately undergoing phagocytosis.
Clinical examples of complement-dependent damage
A number of severe pathological conditions develop via the pathway described above:
- Transfusion reactions. Occur during incompatible donor blood transfusions, when host antibodies attack and destroy donor erythrocytes.
- Hemolytic disease of the newborn (fetal erythroblastosis). Develops due to antigenic differences between mother and fetus. Maternal IgG antibodies cross the placenta and cause massive destruction of the developing child's red blood cells.
- Autoimmune cytopenias. Conditions in which the body produces antibodies against its own blood cells, leading to their destruction. Examples include autoimmune hemolytic anemia, thrombocytopenia, and agranulocytosis.
- Drug-induced reactions. Certain medications can bind to erythrocyte antigens, forming a complex that is attacked by antibodies.
Antibody-dependent cellular cytotoxicity
The main feature of this mechanism is that it proceeds without complement fixation. The process begins when target cells are coated with low concentrations of IgG antibodies.
Unsensitized effector cells then come into play: monocytes, neutrophils, eosinophils, or natural killer (NK) cells. All of them bear special Fc receptors on their surface. Effectors bind to the Fc fragment of the IgG deposited on the target and induce direct cell lysis. Phagocytosis does not occur in this process. Clinically, this mechanism plays a crucial role in graft rejection reactions.
Antibody-mediated cell dysfunction
This is a unique variant of type II hypersensitivity in which antibodies bind to cell surface receptors but do not cause tissue damage or inflammation. Instead, they disrupt normal cellular function.
A classic clinical example of this condition is myasthenia gravis (Myasthenia gravis). In this disease, antibodies react with acetylcholine receptors located at the motor endplates of skeletal muscles. As a result, neuromuscular transmission is blocked, leading to pronounced muscle weakness.
Briefly: answers to topical questions
What diseases, other than myasthenia gravis, develop through the mechanism of antibody-mediated cell dysfunction?
Graves' disease develops through the mechanism of antibody-mediated cell dysfunction.
- Graves' disease is a condition characterized by the production of stimulating autoantibodies against the thyroid-stimulating hormone receptor.
These IgG immunoglobulins bind to thyrocyte receptors and act as TSH agonists. As a result, hormone production is stimulated and cell hyperfunction occurs without direct cell damage.
Which components of the complement system act as opsonins in type II hypersensitivity?
The complement component C3b acts as an opsonin in complement-dependent type II hypersensitivity reactions.
- C3b is fixed on the cell surface.
- As a result, such a cell becomes a target for phagocytes and undergoes phagocytosis.
Effector cells in cellular cytotoxicity are easily remembered by the mnemonic: Monocytes, Neutrophils, Eosinophils, Natural killer cells (NK cells).
Class and exam questions
Which antibody classes participate in type II hypersensitivity reactions?
IgG and IgM immunoglobulins play the primary role. They bind to antigens on cell membranes and trigger mechanisms of damage.
What is the difference between direct lysis and opsonization during complement activation?
During direct lysis, the membrane attack complex (MAC) forms, which punctures the membrane and destroys the cell. During opsonization, the cell is coated with antibodies or the C3b component, becoming a target for subsequent phagocytosis.
How do drug-induced type II reactions develop?
A drug settles on the cell surface (e.g., an erythrocyte) and forms a complex with its antigen. The immune system produces antibodies that attack this complex, destroying the cell itself.
Does type II hypersensitivity always lead to target cell death?
No. There is a mechanism of antibody-mediated dysfunction in which antibodies merely block cellular receptors. For example, in myasthenia gravis, neuromuscular transmission is impaired, but no physical tissue damage or inflammation occurs.
What else to study on this topic
- Complement system activation cascade: from C1q binding to the formation of the membrane attack complex (MAC)
- Pathogenesis of autoimmune cytopenias: mechanisms of destruction of erythrocytes, leukocytes, and platelets
- The role of effector cell Fc receptors in antibody-dependent cellular cytotoxicity
- Mechanisms of neuromuscular transmission impairment in Myasthenia gravis
- Features of maternal IgG placental transfer in fetal erythroblastosis
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Type II hypersensitivity" and 4,414 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in the section «Immunopathological processes»
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.